Protective Effects of Live Combined B. subtilis and E. faecium in Polymicrobial Sepsis Through Modulating Activation and Transformation of Macrophages and Mast Cells

被引:22
作者
Guo, Lisha [1 ,2 ]
Meng, Mei [1 ]
Wei, Yaping [3 ]
Lin, Feixue [4 ]
Jiang, Ying [5 ]
Cui, Xianzhen [5 ]
Wang, Guirong [6 ]
Wang, Chunting [1 ]
Guo, Xiaosun [3 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Dept Crit Care Med, Jinan, Shandong, Peoples R China
[2] Binzhou Med Univ Hosp, Dept Emergency, Binzhou, Peoples R China
[3] Shandong Univ, Sch Basic Med, Dept Physiol & Pathophysiol, Jinan, Shandong, Peoples R China
[4] Binzhou Med Univ Hosp, Binzhou, Peoples R China
[5] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China
[6] SUNY Upstate Med Univ, Dept Surg, Syracuse, NY 13210 USA
基金
中国国家自然科学基金;
关键词
AKT pathway; live combined Bacillus subtilis and Enterococcus faecium (LCBE) enteric-coated capsules; macrophage activation and transformation; mast cell degranulation; CLP sepsis; GUT; MOTOR; PROBIOTICS; MECHANISM;
D O I
10.3389/fphar.2018.01506
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims: Clinical studies showed that the use of probiotics during critical illness reduced nosocomial infection and improved clinical outcome. However, the functional mechanisms of probiotics is remains unclear. Therefore the aim of current study is to explore the protective effects and understand the underlying mechanisms for the beneficial effects of live combined Bacillus subtilis and Enterococcus faecium (LCBE) in cecal ligation puncture (CLP)-induced sepsis. Methods and Results: Seven-week-old C57BL/6J mice were divided into three groups: sham group (6 mice), CLP-control group (20 mice, pretreatment with saline for 7 days before CLP surgery) and CLP-probiotics group (14 mice, pretreatment with LCBE enteric-coated capsules for 7 days before CLP surgery). In survival experiment, mice were monitored for 7 days after CLP. After the procedure, mice were sacrificed, and, serum, and peritoneal lavage fluid were collected and intestinal ileal samples were harvested. Results: Our results showed that the mortality was significantly reduced in mice CLP-probiotics group vs. CLP-control group (P < 0.05). Also, treatment CLP-probiotics group decreased the injury scores CLP-probiotics group when compared to CLP-control group. Additionally, levels of pro-inflammatory cytokines IL-6 and TNF-alpha levels in the serum and intestinal ileal tissues of CLP-probiotics group were reduced when compared to CLP-control group (P < 0.05). However, no significant differences in anti-inflammatory levels of IL-10 and TGF-beta 1 were observed between CLP-control and CLP-probiotic groups. Furthermore, our experiments showed that that probiotic treatment suppressed the macrophage activation and transformation from M-type to M1-type, inhibited the mast cells (MCs) degranulation, and activation of AKT (kinase B) pathway. Conclusion: In conclusion, our data shows that probiotics have a protective role in CLP septic mice through reducing intestinal inflammation, altering macrophage polarization and MCs degranulation, and regulating AKT signaling. Significance and Impact of Study: This study demonstrated the protective effects and mechanisms involved in the protective role of live combined Bacillus subtilis and Enterococcus faecium (LCBE) in CLP-induced septic mice model.
引用
收藏
页数:11
相关论文
共 39 条
[1]   The mechanism of action of probiotics [J].
Boirivant, Monica ;
Strober, Warren .
CURRENT OPINION IN GASTROENTEROLOGY, 2007, 23 (06) :679-692
[2]   Histaminergic Angioedema [J].
Busse, Paula J. ;
Smith, Tukisa .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2017, 37 (03) :467-+
[3]   Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis [J].
Chen, Lufang ;
Xu, Keying ;
Gui, Qifeng ;
Chen, Yue ;
Chen, Deying ;
Yang, Yunmei .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (03) :1836-1842
[4]   Mast cell dipeptidyl peptidase I mediates survival from sepsis [J].
Clair, JMS ;
Pham, CTN ;
Villalta, SA ;
Caughey, GH ;
Wolters, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (04) :628-634
[5]   Intestinal crosstalk: A new paradigm for understanding the gut as the "motor" of critical illness [J].
Clark, Jessica A. ;
Coopersmith, Craig M. .
SHOCK, 2007, 28 (04) :384-393
[6]   Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment [J].
Clark, Jessica A. ;
Doelle, Sarah M. ;
Halpern, Melissa D. ;
Saunders, Tara A. ;
Holubec, Hana ;
Dvorak, Katerina ;
Boitano, Scott A. ;
Dvorak, Bohuslav .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 291 (05) :G938-G949
[7]   Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis [J].
Dahdah, Albert ;
Gautier, Gregory ;
Attout, Tarik ;
Fiore, Frederic ;
Lebourdais, Emeline ;
Msallam, Rasha ;
Daeron, Marc ;
Monteiro, Renato C. ;
Benhamou, Marc ;
Charles, Nicolas ;
Davoust, Jean ;
Blank, Ulrich ;
Malissen, Bernard ;
Launay, Pierre .
JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (10) :4577-4589
[8]   Synthetic Biology and the Gut Microbiome [J].
Dou, Jennifer ;
Bennett, Matthew R. .
BIOTECHNOLOGY JOURNAL, 2018, 13 (05)
[9]   Probiotics in the Mechanism of Protection Against Gut Inflammation and Therapy of Gastrointestinal Disorders [J].
Dylag, Katarzyna ;
Hubalewska-Mazgaj, Magdalena ;
Surmiak, Marcin ;
Szmyd, Jakub ;
Brzozowski, Tomasz .
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (07) :1149-1155
[10]  
Echtenacher B., 1996, CRITICAL PROTECTIVE